EVAX Reports $1.2B Revenue, $0.05 EPS, +150% YoY, Announces $200M Cancer Vaccine Trial, Cash to 2027
Evaxion A/S American Depositary Share · Now $3.90
+6.6% in 1d after detection
Post-detection moves
1h
—
1d
+6.6%
3d
+2.5%
7d
+0.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS